Mr. Martin Ostrowski is Chief Legal Officer at Kenai Therapeutics. Recently as Co-Founder of two biotech spin-outs in the advanced medicine sector, he raised over $15 million while leading intellectual property licensing & portfolio development and operations. Mr. Ostrowski previously served as Director of Intellectual Property and Business Development at Cellscript, practiced law at Sughrue Mion, PLLC, and led the business development operations at Arteriocyte and Arteriocyte Medical Systems. His professional career has spanned academic research, business development and commercialization activities, prosecuting and litigating domestic and international intellectual property, and leadership roles in different biotechnology and pharma-based commercial entities.

Mr. Ostrowski received his Bachelor of Science in bioengineering from Arizona State University. He also holds a Master of Science in biochemistry and Doctor of Law from Case Western University.